CT and MR imaging of benign hepatic and biliary tumors

Radiographics

Volumn 19, Issue 2, 1999, Pages 431-451

  Horton, Karen M ^a   Bluemke, David A ^a   Hruban, Ralph H ^a   Soyer, Philippe ^b   Fishman, Elliot K ^a  

^a JOHNS HOPKINS HOSPITAL   (United States)

^b HÔPITAL LARIBOISIÈRE   (France)

Author keywords

Bile ducts, CT, 76.1211; Bile ducts, MR, 76.1214; Bile ducts, neoplasms, 76.31; Liver neoplasms, 761.31 Liver neoplasms, CT, 761.1211; Liver neoplasms, diagnosis, 761.1211, 761.1214; Liver neoplasms, MR, 761.1214

Indexed keywords

CONTRAST MEDIUM;

BILIARY TRACT TUMOR; COMPUTER ASSISTED TOMOGRAPHY; DIFFERENTIAL DIAGNOSIS; HUMAN; LIVER TUMOR; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; REVIEW;

BILIARY TRACT NEOPLASMS; CONTRAST MEDIA; DIAGNOSIS, DIFFERENTIAL; HUMANS; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0033093361     PISSN: 02715333     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiographics.19.2.g99mr04431     Document Type: Article

References (30)

1. Vogl T, Hammerstingl R, Schwarz W, et al. Superparamagnetic iron oxide: enhanced versus gadolinium-enhanced MR imaging for differential diagnosis of focal liver lesions. Radiology 1996; 198:881-887.
2. Schwartz L, Seltzer S, Tempany C, et al. Superparamagnetic iron oxide hepatic MR imaging: efficacy and safety using conventional and fast spin-echo pulse sequences. J Magn Reson Imaging 1995; 5:566-570.
3. Grandin C, VanBeers B, Robert A, Gigot J, Geugel A, Pringot J. Benign hepatocellular tumors: MRI after superparamagnetic iron oxide administration. J Comput Assist Tomogr 1995; 193:412-418.
4. Ferrucci J, Stark D. Iron oxide-enhanced MR imaging of the liver and spleen: review of the first 5 years. AJR 1990; 155:943-950.
5. Ohtomo K, Itai Y, Yoshikawa K, Kokubo T, Ilo M. Hepatocellular carcinoma and cavernous hemangioma: differentiation with MR imaging - efficacy of T2 values at 0.35 and 1.5T. Radiology 1988; 168:621-623.
6. Mathieu D, Bruneton J, Drouillard J, Pointreau C, Vasile N. Hepatic adenomas and focal nodular hyperplasia: dynamic CT study. Radiology 1986; 160:53-58.
7. Nghiem H, Bogost G, Ryan J, Lund P, Freeny P, Rice K. Cavernous hemangiomas of the liver: enlargement over time. AJR 1997; 169:137-140.
8. Quinn S, Benjamin G. Hepatic cavernous hemangiomas: simple diagnostic sign with dynamic bolus CT. Radiology 1992; 182:545-548.
9. Ashida C, Fishman E, Zerhouni E, et al. Computed tomography of hepatic cavernous hemangioma. J Comput Assist Tomogr 1983; 1983:455-460.
10. Itoh K, Saini S, Hahn P, Imam N, Ferucci J. Differentiation between small hepatic hemangiomas and metastases on MR: importance of size-specific quantitative criteria. AJR 1990; 155: 61-66.
11. Buetow P, Pantongrag-Brown L, Buck J, Ross P, Goodman Z. Focal nodular hyperplasia of the liver: radiologic-pathologic correlation. RadioGraphics 1996; 16:369-388.
12. Nagorney D. Benign hepatic tumors: focal nodular hyperplasia and hepatocellular adenoma. World J Surg 1995; 19:13-18.
13. Foster J, Berman M. The malignant transformation of liver cell adenomas. Arch Surg 1994; 129:712-717.
14. Keslar P, Buck J, Selby D. Infantile hemangioendothelioma of the liver revisited. RadioGraphics 1993; 13:657-670.
15. Weinberg A, Fiengold M. Primary hepatic tumors of childhood. Hum Pathol 1983; 14:512-537.
16. Selby D, Stocker J, Ishak K. Angiosarcoma of the liver in childhood: a clinicopathologic follow-up study of 10 cases. Pediatr Pathol 1992; 12:485-498.
17. Lucaya J, Enriquez G, Amat L, Gonzalez-Rivero M. Computed tomography of infantile hemangioendothelioma. AJR 1985; 144:821-826.
18. George J, Cohen M, Tarver R, Rosales R. Ruptured cystic mesenchymal hamartoma: an unusual cause of neonatal ascites. Pediatr Radiol 1994; 24:304-305.
19. Ros P, Goodman Z, KG Ishak, et al. Mesenchymal hamartoma of the liver: radiologic-pathologic correlation. Radiology 1986; 158:619-624.
20. Hooper L, Mergo P, Ros P. Multiple hepatorenal angiomyolipomas: diagnosis with fat suppression, gadoliniun enhanced MRI. Abdom Imaging 1994; 19:549-551.
21. Roberts R, Fishman E, Hartman D, Sanders R, Goodman Z, Siegelman S. Lipomatous tumors of the liver: evaluation with CT and US. Radiology 1986; 158:613-617.
22. Bruneton J, Kerboul P, Drouillard J, Menu Y, Normand F, Santini N. Hepatic lipomas: ultrasound and computed tomographic findings. Gastrointest Radiol 1987; 12:299-303.
23. Kokal K, Abraham P, Pimparker B, Desai A, Bapat R. Biliary cystadenoma of the liver. J Postgrad Med 1983; 29:53-55.
24. Sanchez H, Gagner M, Roosi R, et al. Surgical management of nonparasitic cystic liver disease. Am J Surg 1991; 161:113-119.
25. Fairchild R, Reese J, Solomon H, Garvin P, Esterl R. Biliary cystadenoma: a case report and review of the literature. Mo Med 1993; 90:656-657.
26. Frick M, Feinberg S. Biliary cystadenoma. AJR 1982; 139:393-395.
27. Bonfors M. The development of cholangiocarcinoma from multiple bile duct hamartomas. Acta Pathol Microbiol Immunol Scand 1984; 2:235-238.
28. Sada PN, Ramakrishna B. Computed tomography of von Meyenburg complex simulating microabscesses. Australas Radiol 1994; 38: 225-226.
29. Eisenberg D, Hurwitz L, Yu A. CT and sonography of multiple bile duct hamartomas simulating malignant disease. AJR 1986; 147:279-280.
30. Allaire G, Rabin L, Ishak K, Sesterhenn I. Bile duct adenoma: a study of 152 cases. Am J Surg Pathol 1988; 12:708-715.